Azepine derivatives as pharmaceutical agents
US8466143B2 · kind B2 · utility
1Cited by
4References
43Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 2004 |
| Grant date | Jun 18, 2013 |
| Priority date | — |
| Expiry date | Nov 7, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds, compositions and methods are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder related to the activity of the receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.